Printing metal-spiked inks for LA-ICP-MS bioimaging internal standardization: Comparison of the different nephrotoxic behavior of cisplatin, carboplatin, and oxaliplatin

Analytical and Bioanalytical Chemistry

Volumn 408, Issue 9, 2016, Pages 2309-2318

  Moraleja, Irene ^a   Esteban Fernández, Diego ^b   Lázaro, Alberto ^c   Humanes, Blanca ^c   Neumann, Boris ^d,e   Tejedor, Alberto ^c   Mena, M Luz ^a   Jakubowski, Norbert ^b   Gómez Gómez, M Milagros ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b BAM FEDERAL INSTITUTE FOR MATERIALS RESEARCH AND TESTING   (Germany)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d PROTEOME FACTORY AG   (Germany)

^e DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Bioimaging; LA ICP MS; Nephrotoxicity; Printed internal standard; Pt based drugs

Indexed keywords

ABLATION; DRUG DOSAGE; FIGHTER AIRCRAFT; HISTOLOGY; INDUCTIVELY COUPLED PLASMA; INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY; INK; INK JET PRINTERS; LASER ABLATION; MASS SPECTROMETERS; STANDARDIZATION; TISSUE; TRACE ELEMENTS;

BIO-IMAGING; HOMOGENEOUS DISTRIBUTION; INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRIES (ICPMS); INTERNAL STANDARDIZATION; INTERNAL STANDARDS; LA-ICP-MS; LASER ABLATION INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRIES (LA ICP MS); NEPHROTOXICITY;

TISSUE ENGINEERING;

CARBOPLATIN; CISPLATIN; INK; OXALIPLATIN; PLATINUM COMPLEX;

ANIMAL; COMPARATIVE STUDY; DRUG EFFECTS; KIDNEY; METABOLISM; PRINTING; RAT; STANDARD;

ANIMALS; CARBOPLATIN; CISPLATIN; INK; KIDNEY; ORGANOPLATINUM COMPOUNDS; PRINTING; RATS; REFERENCE STANDARDS;

EID: 84955588437     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-016-9327-0     Document Type: Article

References (32)

1. Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: a review. Am J Med Sci. 2007;334:115-24. doi: 10.1097/MAJ.0b013e31812dfe1e.
2. Moreno-Gordaliza E, Giesen C, Lázaro A, Esteban-Fernández D, Humanes B, Cañas B, et al. Elemental bioimaging in kidney by LA-ICP-MS as a tool to study nephrotoxicity and renal protective strategies in cisplatin therapies. Anal Chem. 2011;83:7933-40. doi: 10.1021/ac201933x.
3. Yonezawa A, Inui KI. Organic cation transporter OCT/SLC22A and H+/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agents. Biochem Pharmacol. 2011;81:563-8. doi: 10.1016/j.bcp.2010.11.016.
4. Husain K, Jagannathan R, Hasan Z, Trammell GL, Rybak LP, Hazelrigg SR, et al. Dose response of carboplatin-induced nephrotoxicity in rats. Pharmacol Toxicol. 2002;91:83-9.
5. Esteban-Fernández D, Gómez-Gómez MM, Cañas B, Verdaguer JM, Ramírez R, Palacios MA. Speciation analysis of platinum antitumoral drugs in impacted tissues. Talanta. 2007;72:768-73. doi: 10.1016/j.talanta.2006.12.012.
6. Esteban-Fernández D, Verdaguer JM, Ramírez-Camacho R, Palacios MA, Gómez-Gómez MM. Accumulation, fractionation, and analysis of platinum in toxicologically affected tissues after cisplatin, oxaliplatin, and carboplatin administration. J Anal Toxicol. 2008;32:140-6.
7. Becker JS. J Mass Spectrom. 2013;48:255-68.
8. Becker JS, Matusch A, Wu B. Bioimaging mass spectrometry of trace elements - recent advance and applications of LA-ICP-MS: a review. Anal Chim Acta. 2014;835:1-18. doi: 10.1016/j.aca.2014.04.048.
9. Lobinski R, Moulin C, Ortega R. Biochimie. 2006;88:1591-604.
10. Heeren RMA, McDonnell LA, Amstalden E, Luxembourg SL, Altelaar AFM, Piersma SR. Appl Surf Sci. 2006;252:6827-35.
11. Gholap DS, Izmer A, De Samber B, Van Elteren JT, Selih VS, Evens R, et al. Anal Chim Acta. 2010;664:19-26.
12. Zoriy M, Matusch A, Spruss T, Becker JS. Laser ablation inductively coupled plasma mass spectrometry for imaging of copper, zinc, and platinum in thin sections of a kidney from a mouse treated with cis-platin. Int J Mass Spectrom. 2007;260:102-6. doi: 10.1016/j.ijms.2006.09.012.
13. Reifschneider O, Wehe CA, Diebold K, Becker C, Sperling M, Karst U. Elemental bioimaging of haematoxylin and eosin-stained tissues by laser ablation ICP-MS. J Anal At Spectrom. 2013;28:989-93.
14. Reifschneider O, Wehe CA, Raj I, Ehmcke J, Ciarimboli G, Sperling M, et al. Quantitative bioimaging of platinum in polymer embedded mouse organs using laser ablation ICP-MS. Metallomics. 2013;5:1440-7. doi: 10.1039/c3mt00147d.
15. Bonta M, Lohninger H, Laszlo V, Hegedus B, Limbeck A. Quantitative LA-ICP-MS imaging of platinum in chemotherapy treated human malignant pleural mesothelioma samples using printed patterns as standard. J Anal At Spectrom. 2014;29:2159-67.
16. Egger AE, Theiner S, Kornauth C, Heffeter P, Berger W, et al. Quantitative bioimaging by LA-ICP-MS: a methodological study on the distribution of Pt and Ru in viscera originating from cisplatin- and KP1339-treated mice. Metallomics. 2014;6. doi: 10.1039/C4MT00072B.
17. Gholap D, Verhulst J, Ceelen W, Vanhaecke F. Use of pneumatic nebulization and laser ablation-inductively coupled plasma-mass spectrometry to study the distribution and bioavailability of an intraperitoneally administered Pt-containing chemotherapeutic drug. Anal Bioanal Chem. 2012;402:2121-9. doi: 10.1007/s00216-011-5654-3.
18. Frick DA, Günther D. Fundamental studies on the ablation behaviour of carbon in LA-ICP-MS with respect to the suitability as internal standard. J Anal At Spectrom. 2012;27:1294. doi: 10.1039/c2ja30072a.
19. Becker JS, Becker JS. Imaging of metals, metalloids, and non-metals by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) in biological tissues. Methods Mol Biol. 2010;656:51-82.
20. Austin C, Fryer F, Lear J, Bishop D, Hare D, Rawling T, et al. Factors affecting internal standard selection for quantitative elemental bio-imaging of soft tissues by LA-ICP-MS. J Anal At Spectrom. 2011;26:1494. doi: 10.1039/c0ja00267d.
21. Austin C, Hare D, Rawling T, McDonagh AM, Doble PJ. J Anal At Spectrom. 2010;25:722-5.
22. Konz I, Fernández B, Fernández ML, Pereiro R, González H, Álvarez L, et al. Gold internal standard correction for elemental imaging of soft tissue sections by LA-ICP-MS: element distribution in eye microstructures. Anal Bioanal Chem. 2013;405:3091-6. doi: 10.1007/s00216-013-6778-4.
23. Bellis DJ, Santamaria-Fernandez R. Ink jet patterns as model samples for the development of LA-ICP-SFMS methodology for mapping of elemental distribution with reference to biological samples. J Anal At Spectrom. 2010;25:957. doi: 10.1039/b926430b.
24. Hoesl S, Neumann B, Techritz S, Linscheid MW, Theuring F, Scheler C, et al. Development of a calibration and standardization procedure for LA-ICP-MS using a conventional ink-jet printer for quantification of proteins in electro- and Western-blot assays. J Anal At Spectrom. 2014;450:1282-91. doi: 10.1039/c4ja00060a.
25. Muldoon LL, Pagel MA, Kroll RA, Brummett RE, Doolittle ND, Zuhowski EG, et al. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity. Clin Cancer Res. 2000;6:309-15.
26. Böhm S, Oriana S, Spatti G, Di Re F, Breasciani G, Pirovano C, et al. Dose intensification of platinum compounds with glutathione protection as induction chemotherapy for advanced ovarian carcinoma. Oncology. 1999;57:115-20.
27. Wandt H, Birkmann J, Denzel T, Schafer K, Schwab G, Pilz D, et al. Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer. Bone Marrow Transplant. 1999;23:763-70. doi: 10.1038/sj.bmt.1701659.
28. Humanes B, Lazaro A, Camano S, Moreno-Gordaliza E, Lazaro JA, Blanco-Codesido M, et al. Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats. Kidney Int. 2012;82:652-63. doi: 10.1038/ki.2012.199.
29. Todd RC, Lippard SJ. Inhibition of transcription by platinum antitumor compounds. Metallomics. 2009;1:280-91. doi: 10.1039/b907567d.
30. Husain K, Whitworth C, Rybak LP. Time response of carboplatin-induced nephrotoxicity in rats. Pharmacol Res. 2004;50:291-300. doi: 10.1016/j.phrs.2004.04.001.
31. Terada T, Inui KI. Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A). Biochem Pharmacol. 2008;75:1689-96. doi: 10.1016/j.bcp.2007.12.008.
32. Yonezawa A, Masuda S, Yokoo S, Katsura T, Inui K-I. Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family). J Pharmacol Exp Ther. 2006;319:879-86. doi: 10.1124/jpet.106.110346.lato.